Clinical Study

Randomized Phase III Study Of Focal Radiation Therapy For Unresectable, Localized Intrahepatic Cholangiocarcinoma

Posted Date: Oct 20, 2016

  • Investigator: Kevin Redmond
  • Co-Investigator: Elizabeth Miyagawa
  • Specialties: Hematology/Oncology, Oncology, Cancer, Radiation Oncology
  • Type of Study: Drug

There are two usual approaches for treating this type of cancer, chemotherapy (gemcitabine and cisplatin) or radiation therapy. The purpose of this study is to compare any good and bad side effects of using the combination of gemcitabine and cisplatin wit

Criteria:

To Be Eligible For This Study, Patients Must Have Intrahepatic Cholangiocarcinoma (A Type Of Liver Cancer).

Keywords:

Nrg-Gi001, Icc, Cancer, Unresectable, Intrahepatic Cholangiocarcinoma

For More Information:

Uc Cancer Institute
513-584-7698
kastla@uc.edu

  • Search Clinical Studies

  • Research in the News

    Ride Cincinnati Gives $200,000 in Grants for Breast Cancer Research

    Marlene Harris-Ride Cincinnati has continued its support of UC Cancer Institutescientists with the annual award of five grants to continue promising breastcancer research.